NAGE
Price
$7.38
Change
+$0.19 (+2.64%)
Updated
Apr 24 closing price
Capitalization
573.8M
12 days until earnings call
ORMP
Price
$2.30
Change
-$0.01 (-0.43%)
Updated
Apr 24 closing price
Capitalization
93.96M
33 days until earnings call
Ad is loading...

NAGE vs ORMP

Header iconNAGE vs ORMP Comparison
Open Charts NAGE vs ORMPBanner chart's image
Niagen Bioscience
Price$7.38
Change+$0.19 (+2.64%)
Volume$396.33K
Capitalization573.8M
Oramed Pharmaceuticals
Price$2.30
Change-$0.01 (-0.43%)
Volume$24.56K
Capitalization93.96M
NAGE vs ORMP Comparison Chart
Loading...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAGE vs. ORMP commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAGE is a StrongBuy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (NAGE: $7.38 vs. ORMP: $2.30)
Brand notoriety: NAGE and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAGE: 37% vs. ORMP: 20%
Market capitalization -- NAGE: $573.8M vs. ORMP: $93.96M
NAGE [@Biotechnology] is valued at $573.8M. ORMP’s [@Biotechnology] market capitalization is $93.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAGE’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • NAGE’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, NAGE is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAGE’s TA Score shows that 6 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • NAGE’s TA Score: 6 bullish, 4 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both NAGE and ORMP are a good buy in the short-term.

Price Growth

NAGE (@Biotechnology) experienced а +9.17% price change this week, while ORMP (@Biotechnology) price change was +6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

NAGE is expected to report earnings on Aug 06, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($574M) has a higher market cap than ORMP($94M). NAGE has higher P/E ratio than ORMP: NAGE (67.09) vs ORMP (20.91). NAGE YTD gains are higher at: 39.114 vs. ORMP (-4.959).
NAGEORMPNAGE / ORMP
Capitalization574M94M611%
EBITDAN/A9.44M-
Gain YTD39.114-4.959-789%
P/E Ratio67.0920.91321%
RevenueN/A0-
Total CashN/A142M-
Total DebtN/A429K-
FUNDAMENTALS RATINGS
NAGE vs ORMP: Fundamental Ratings
NAGE
ORMP
OUTLOOK RATING
1..100
1710
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
4180
PRICE GROWTH RATING
1..100
3654
P/E GROWTH RATING
1..100
9842
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (68) in the Pharmaceuticals Other industry is in the same range as NAGE (83) in the Chemicals Specialty industry. This means that ORMP’s stock grew similarly to NAGE’s over the last 12 months.

NAGE's Profit vs Risk Rating (75) in the Chemicals Specialty industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to ORMP’s over the last 12 months.

NAGE's SMR Rating (41) in the Chemicals Specialty industry is somewhat better than the same rating for ORMP (80) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew somewhat faster than ORMP’s over the last 12 months.

NAGE's Price Growth Rating (36) in the Chemicals Specialty industry is in the same range as ORMP (54) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for NAGE (98) in the Chemicals Specialty industry. This means that ORMP’s stock grew somewhat faster than NAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAGEORMP
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
82%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHDVX12.810.14
+1.10%
Cullen High Dividend Equity I
OPPAX85.54N/A
N/A
Invesco Global A
NWXRX10.49N/A
N/A
Nationwide Small Cap Index Instl Svc
GCAVX18.12N/A
N/A
GMO US Small Cap Value VI
PGRTX12.67N/A
N/A
Principal SmallCap Growth I Instl

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
+2.64%
AXON - NAGE
43%
Loosely correlated
+2.39%
MDGL - NAGE
39%
Loosely correlated
+3.61%
ORMP - NAGE
35%
Loosely correlated
-0.43%
AMRN - NAGE
35%
Loosely correlated
+7.92%
CYTK - NAGE
35%
Loosely correlated
+6.13%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-0.43%
BTAI - ORMP
44%
Loosely correlated
+9.47%
INO - ORMP
44%
Loosely correlated
+2.67%
MBIO - ORMP
44%
Loosely correlated
-6.72%
VERV - ORMP
44%
Loosely correlated
+5.67%
ZNTL - ORMP
43%
Loosely correlated
+0.67%
More